| Literature DB >> 32405356 |
Alhamzah Hasan Waheed Janabi1, Asghar Ali Kamboh2, Muhammad Saeed3, Lu Xiaoyu1, Jannat BiBi4, Fatima Majeed5, Muhammad Naveed6, Muhammad Jameel Mughal7, Nazar Ali Korejo8, Rubina Kamboh9, Mahmoud Alagawany10, Huixia Lv1.
Abstract
It is well documented that life expectancy in developed countries at birth is going to surpass the 20th century. However, regrettably, a potential decline in life expectancy has been proposed for these nations in the 21st century due to a rapid upsurge in the prevalence of fatal degenerative diseases like cardiovascular diseases (CVD), cancer and diabetes. Collectively, these three diseases accounted for 65% of all deaths in urbanized societies and were considered as a dynamic issue for shortening the genetically determined lifespan through increased mortalities, morbidities, disabilities, immense sufferings, and premature aging. These fatal degenerative diseases and premature aging are closely associated with oxidative stress produced by the free radicals in the body. In epidemiologic studies, flavonoid-rich foods (FRF) like fruits, vegetables, and beverages have been associated as protective agents against these diseases. These also have been observed for their geroprotective effects and help in preventing premature aging and deterioration of brain function, which is related to Alzheimer's disease and dementia. In this review, we presented a comprehensive overview of the FRF for their potential role against lifespan-shortening complications, i.e., CVD, cancer, and diabetes. We also have drawn the future perspective and dietary guidelines to reduce the fatal disease burden in urban populations.Entities:
Keywords: Anti-oxidants; Cancers geroprotective; Cardiovascular diseases; Diabetes; Dietary supplements; Nutraceuticals
Year: 2020 PMID: 32405356 PMCID: PMC7211351 DOI: 10.22038/IJBMS.2019.35125.8353
Source DB: PubMed Journal: Iran J Basic Med Sci ISSN: 2008-3866 Impact factor: 2.699
Figure 1A. Mean concentration of flavonols (mg/100 g) in different food sources. B. Mean concentration of flavanones (mg/100 g) in various food sources. C. Mean concentration of flavanols (mg/100 g) in different food sources. For green and black tea, leaves to water ratio are 1:20 (w/v). D. Mean concentration of anthocyanins (mg/100 g) in different food sources E. Mean concentration of flavones (mg/100 g) in various food sources (37)
Figure 2Basic chemical structural and types of flavonoids. A: Molecular structure of flavones backbone (2-phenyl-1,4-benzopyrene). B & C: isoflavan and neoflavonoids structures
Figure 3Pharmacokinetics of dietary flavonoids
Figure 4The schematic overview of the therapeutic properties of flavonoid-rich foods
Effects of flavonoids rich-foods against lifespan-shortening diseases
|
|
|
|
|---|---|---|
| Pomegranate | Anticancer | [ |
| Fruits/vegetables | Anti-hypertension, reduced risk of diabetes, anti-hypercholesterolemia, anti-obesity, ↓ cardiovascular diseases, ↓ breast cancer, ↓ coronary heart diseases | [ |
| Whole grains | Reduced risk of diabetes, anticancer | [ |
| Coffee | Reduced risk of type 2 diabetes | [ |
| Berries | ↓Prostate cancer, reduced risk of type 2 diabetes | [ |
| Green tea | Reduced risk of type 2 diabetes, ↓ blood glucose, anticancer | [ |
| Apple | Reduced risk of type 2 diabetes, ↓ breast cancer, ↓ cardiovascular diseases | [ |
| Black tea | ↓Blood glucose, ↓ total and LDL cholesterol, ↓ myocardial infarction, reduced risk of coronary heart disease | [ |
| Onion | Antihyperglycemic effects, ↓ breast cancer | [ |
| Garlic | Anti-platelet aggregation, modification of LDL, antihyperglycemic effects, anticancer | [ |
| Cruciferous vegetables | Anticancer | [ |
| Cabbage | Anticancer, ↓ vascular diseases | [ |
| Broccoli | Anticancer, ↓ prostate cancer | [ |
| Cauliflower | Anticancer, ↓ prostate cancer | [ |
| Brussels sprouts | Anticancer | [ |
| Soy | Reduced risk of breast and prostate cancer | [ |
| Citrus fruits | Antiproliferative, ↓ vascular diseases | [ |
| Tomato | ↓ Prostate cancer | [ |
| Turmeric | Anti-hepatocarcinogenesis, anticancer | [ |
| Ginger | Inhibit platelet aggregation, anticancer, anti-thrombotic | [ |
| Carrots | Anticancer | [ |
↓: decreased; LDL: low-density lipoprotein
Summary of studies indicating reduced mortalities by intake of flavonoids rich-foods (FRF)
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Fruit and vegetable | ≥5 servings/day | Population-based cohort | 71,706 | 13 year | 53 percent higher all-cause mortality rate in those who never consumed fruits and vegetables than those who consumed five servings/day | [ |
| Cruciferous vegetable | 144, 232, 307, 398 & 583 g/day | Prospective cohort study | 134,796 | 4.6 year | A dose-response pattern was evident for increasing quintiles of cruciferous vegetables intake and reduction in total mortality as well as CVD mortality | [ |
| Fruit and vegetables | 178.8, 316.8, 468.4 & 725.4 g/day | Population cohort study | 451,151 | 10 year | A stronger association was observed for raw vegetable and fruit consumption and reduction in all-cause mortality as well as CVD mortality | [ |
| Coffee | 1 to >6 cups/day | Cohort study | 41, 836 | 15 year | 1-3 cups/d significantly reduced the mortality from CVD and other inflammatory diseases in postmenopausal women | [ |
| Green tea | 1 to >5 cups/day | A population-based, prospective cohort study | 40, 530 | 11 year | A 16% lowered mortality from all-cause and CVD in people who consumed 5 or more cups/day than those consuming less than 1 cup/day | [ |
| Fruit, vegetable, and beans | Fruit: 0.9, 2.3, 3.9 &5.9 servings/wk; | Cohort study | 59,485 | 13 year | Fruit intake followed by vegetable and bean intake exhibited the significant inverse association for total and CVD mortality | [ |
| Whole grains | ≥3 servings/ day | Cross-sectional study | 535 | 3 year | A significant inverse association was recorded for whole-grain intake and mortality from CVD | [ |
| Green-yellow vegetables and fruits | ≤ 1, 2-4 servings/wk and one serving daily | Prospective study | 38, 540 | 18 year | Subjects had 12% lower mortality from all cancers and 20% lower mortality from lung and stomach cancer; as well as 8% lower mortality from all cancers and 25% lower mortality from liver cancer, those consuming 1 or about 1 serving/day of fruits and green-yellow vegetables, respectively, comparing with those who ate these foods once per week or less. | [ |
| Fruit and vegetables | 0.87, 1.61, 2.31, 3.21 & 4.89 servings/day | Prospective study | 6,151 | 13 year | Compared with the bottom fifth, highest fifth of fruit and vegetable consumers had a significantly lower all-cause, cancer, and CVD mortality | [ |
| Fruit and vegetables | < 5 to ≥5 servings/d | Cohort study | 501 | 18 year | Individuals consumed the combination of ≥5 servings/day of fruits and vegetables and ≤12 energy from saturated fat had lower all-cause (31%) and CVD (76%) mortality, compared with those consuming <5 servings/day of fruits and vegetables and >12% saturated fats | [ |
| Fruit and vegetables | <1 to 8 times/day | Cohort study | 9,608 | 19 year | Fruit and vegetable consumption ≥3 times/day as compared with <1 time/day significantly reduce stroke mortality (42%), ischemic heart disease mortality (24%), CVD mortality (27%), and all-cause mortality (15%) | [ |
| Fruits | 0-1, 2-3, 4-5, 6-7 times/wk | Prospective cohort study | 792 | 26 year | Significantly lower total and CVD mortality were recorded in men with high fruit consumption. This association existed up to 16 year follow-up (at the age of 70) | [ |
| Fruit, berry, and vegetables | <133, 133-214, 215-293, 294-408 &>408 g/day | Prospective cohort study | 2,641 | 12.8 year | A significantly lower CVD, non-CVD, and all-cause mortality was observed in men with the highest consumption of fruit, vegetable, and berries | [ |
Figure 5The proposed antidiabetic effects of flavonoids foods. ↑ increase; ↓ decrease; AKT: v-akt murine thymoma viral oncogene homolog; HB: hemoglobin; IRS: insulin receptor substrate; HbA1c: glycated hemoglobin; IL-1β: interleukin-1 beta; HMG-CoA: 3-hydroxy-3-methyl glutaryl-coenzyme A; PI3K: phosphatidylinositol-3-kinase; TG: triglycerides; SREBP-1c: sterol regulatory element-binding protein; VLDL: very low density Lipoprotein (71)
Figure 6The schematic overview of the anticancer effects of flavonoid-rich foods. CYP1: cytochrome P450; BCRP: breast cancer resistance protein; AhR: aryl hydrocarbon receptor; Erβ: estrogen receptor β; ROS: reactive oxygen species
Figure 7The cardioprotective effect and implicated mechanisms of flavonoids. (IHD) indicates ischemic heart disease and (LDL), low-density lipoprotein cholesterol (92)